Abstract:Transcription networks and epigenetic mechanisms including DNA methylation, histone modifications, and noncoding RNAs control lineage commitment of multipotent mesenchymal progenitor cells. Proteins that read, write, and erase histone tail modifications curate and interpret the highly intricate histone code. Epigenetic reader proteins that recognize and bind histone marks provide a crucial link between histone modifications and their downstream biological effects. Here, we investigate the role of bromodomain-containing (BRD) proteins, which recognize acetylated histones, during osteogenic differentiation. Using RNA-sequencing (RNA-seq) analysis, we screened for BRD proteins (n = 40) that are robustly expressed in MC3T3 osteoblasts. We focused functional follow-up studies on Brd2 and Brd4 which are highly expressed in MC3T3 preosteoblasts and represent "bromodomain and extra terminal domain" (BET) proteins that are sensitive to pharmacological agents (BET inhibitors). We show that small interfering RNA depletion of Brd4 has stronger inhibitory effects on osteoblast differentiation than Brd2 loss as measured by osteoblast-related gene expression, extracellular matrix deposition, and alkaline phosphatase activity. Similar effects on osteoblast differentiation are seen with the BET inhibitor +JQ1, and this effect is reversible upon its removal indicating that this small molecule has no lasting effects on the differentiation capacity of MC3T3 cells. Mechanistically, we find that Brd4 binds at known Runx2 binding sites in promoters of bone-related genes. Collectively, these findings suggest that Brd4 is recruited to osteoblast-specific genes and may cooperate with bone-related transcription factors to promote osteoblast lineage commitment and maturation.

BRD2 Interconnects with BRD3 to Facilitate Pol II Transcription Initiation and Elongation to Prime Promoters for Cell Differentiation.

Bromodomain and Extraterminal Domain Protein 2 in Multiple Human Diseases.

<b>Bromodomain and Extra-Terminal Domain Protein 2</b><b>in Multiple Human Diseases</b>

BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis

The Functions of BET Proteins in Gene Transcription of Biology and Diseases

A bromodomain-DNA interaction facilitates acetylation-dependent bivalent nucleosome recognition by the BET protein BRDT

BRD4: a general regulator of transcription elongation

KDM5C-mediated recruitment of BRD4 to chromatin regulates enhancer activation and BET inhibitor sensitivity

BRD4 assists elongation of both coding and enhancer RNAs by interacting with acetylated histones

Data from KDM5C-Mediated Recruitment of BRD4 to Chromatin Regulates Enhancer Activation and BET Inhibitor Sensitivity

Brd2 is a TBP-associated Protein and Recruits TBP into E2F-1 Transcriptional Complex in Response to Serum Stimulation

Roles of the BRD4 Short Isoform in Phase Separation and Active Gene Transcription

Structural Basis and Binding Properties of the Second Bromodomain of Brd4 with Acetylated Histone Tails.

The epigenetic reader Brd4 is required for osteoblast differentiation

Brd4 binds to active enhancers to control cell identity gene induction in adipogenesis and myogenesis

Integrating ChIP-sequencing and Digital Gene Expression Profiling to Identify BRD7 Downstream Genes and Construct Their Regulating Network

Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains

DUB3 Promotes BET Inhibitor Resistance and Cancer Progression by Deubiquitinating BRD4.

Study the motif-bromodomain of BRD7 and identify a novel interaction protein with BRD7

The mechanisms behind the therapeutic activity of BET bromodomain inhibition

Lncrnadigitand BRD3 Protein Form Phase-Separated Condensates to Regulate Endoderm Differentiation